Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Generic controlled-release carbamazepine approved in U.K.

April 27, 1998

OHM-3507: a fentanyl derivative with incongruent pharmacological effects

April 24, 1998

AChE inhibitors for Alzheimer's disease disclosed by Sagami

April 24, 1998

Positive phase III results reported for Neurobloc in cervical dystonia

April 24, 1998

Danaparoid sodium is not beneficial for acute ischemic stroke

April 24, 1998

Toray analgesic in clinical development worldwide

April 23, 1998

Suntory researchers discover new treatments for convulsions, ischemia

April 23, 1998

AIT-082 enhances memory function in preclinical model

April 23, 1998

Sepracor receives U.S. patent protection for single-isomer SSRI

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...